NSERecord Date10 Jul 2026 · 10 Jul 2026, 03:23 pm

Record Date

Sudeep Pharma Limited · SUDEEPPHRM

✦ AI SummaryDividend

Sudeep Pharma Limited has announced the record date for the payment of final dividend as July 23, 2026, subject to approval at the 37th Annual General Meeting on August 4, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sudeep Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 23-Jul-2026.

Attachments (1)

📄

SUDEEPPHARMALIMITED_10072026152040_Update_on_Dividend.pdf

pdf

Download →
View document text
Date: 10th July 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Bandra Kurla Phiroze Jeejeebhoy Towers Dalal Street, Complex, Bandra (E), Mumbai – 400051 Mumbai – 400001 Scrip Symbol- SUDEEPPHRM Scrip Code: 544619 Sub: Intimation of Record Date for payment of Final Dividend on Equity Shares for the Financial Year 2025-26 Ref: Regulation 30 and 42 of the SEBI (LODR) Regulations, 2015 (Listing Regulations) Dear Sir/Madam, As informed earlier, the Board of Directors at its meeting held on Thursday, 21st May 2026, had recommended a final dividend of ₹1.50/- per equity share of ₹1 each of the Company for approval by the shareholders at the 37th Annual General Meeting (“AGM”) scheduled to be held on Tuesday, 4th August 2026. Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Thursday, 23rd July 2026 as the Record Date for determining entitlement of Members to final dividend for the FY 2025-26. If the final dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to deduction of tax at source, will be paid within stipulated time period, to all Beneficial Owners in respect of shares held in dematerialized form as per the data as may be made available by the National Securities Depository Limited and the Central Depository Services (India) Limited as of the close of business hours on Thursday, 23rd July 2026; Kindly take note of the same. Thanking You. For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184 CC: 1. National Securities Depository Limited 2. Central Depository Services (India) Limited 3. MUFG Intime India Private Limited CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com